Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular Imaging of Huntington's Disease.
Ciarmiello A, Giovacchini G, Giovannini E, Lazzeri P, Borsò E, Mannironi A, Mansi L. Ciarmiello A, et al. Among authors: lazzeri p. J Cell Physiol. 2017 Aug;232(8):1988-1993. doi: 10.1002/jcp.25666. Epub 2017 Mar 24. J Cell Physiol. 2017. PMID: 27791273 Review.
Clinical applications of choline PET/CT in brain tumors.
Giovannini E, Lazzeri P, Milano A, Gaeta MC, Ciarmiello A. Giovannini E, et al. Among authors: lazzeri p. Curr Pharm Des. 2015;21(1):121-7. doi: 10.2174/1381612820666140915120742. Curr Pharm Des. 2015. PMID: 25225894 Review.
Sensitivity of fluorine-18-fluoromethylcholine PET/CT to prostate-specific antigen over different plasma levels: a retrospective study in a cohort of 192 patients with prostate cancer.
Giovacchini G, Giovannini E, Borsò E, Lazzeri P, Riondato M, Leoncini R, Duce V, Conti E, Picchio M, Ciarmiello A. Giovacchini G, et al. Among authors: lazzeri p. Nucl Med Commun. 2019 Mar;40(3):258-263. doi: 10.1097/MNM.0000000000000959. Nucl Med Commun. 2019. PMID: 30507748
SPECT radiopharmaceuticals for dementia.
Guidotti C, Farioli D, Gaeta MC, Giovannini E, Lazzeri P, Meniconi M, Ciarmiello A. Guidotti C, et al. Among authors: lazzeri p. Curr Radiopharm. 2013 Dec;6(4):192-207. doi: 10.2174/1874471006666131217112006. Curr Radiopharm. 2013. PMID: 24359135 Review.
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
Vaiano A, Claudio Traino A, Boni G, Grosso M, Lazzeri P, Colato C, Davì MV, Francia G, Lazzeri M, Mariani G, Ferdeghini M. Vaiano A, et al. Among authors: lazzeri m, lazzeri p. Nucl Med Commun. 2007 Mar;28(3):215-23. doi: 10.1097/MNM.0b013e328014a0f6. Nucl Med Commun. 2007. PMID: 17264781 Clinical Trial.
No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis.
Federico G, Boni G, Fabiani B, Fiore L, Lazzeri P, Massart F, Traino C, Verola C, Saggese G, Mariani G, Scarpato R. Federico G, et al. Among authors: lazzeri p. Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2113-21. doi: 10.1007/s00259-008-0867-1. Epub 2008 Jul 22. Eur J Nucl Med Mol Imaging. 2008. PMID: 18648806
44 results